Abstract:Background: Protein phosphotylation is one of the essential steps in cell signaling, and aberrant phosphorylation is a common event in human cancer. The expression of receptor type protein tyrosine phosphatase gamma (PTPRG) in normal breast is found to be similar to 50-60% higher than that of breast tumor tissue. Overexpression of PTPRG inhibits anchorage-independent growth and proliferation of breast cancer cells. To understand the tumor suppression characteristics of PTPRG, we studied its tumor suppressive function in an athymic mouse model and evaluated factors that can potentially regulate its expression in breast cancer cells. Materials and Methods: To investigate the function of PTPRG in vivo, athymic nude mice were implanted with MCF-7 cells overexpressing PTPRG. For in vitro study, protein levels of cell cycle regulators, cell cycle re-entry, and the phosphorylation levels of extracellular signal-regulated protein kinases 112 (ERKI/2) were examined. In addition, methylation assays were conducted to investigate the epigenetic modification on the promoter of PTPRG. Results: Athymic nude mice bearing MCF-7 cells overexpressing PTPRG showed a reduction in tumor burden in comparison to animals implanted with MCF-7 cells transfected with vector alone. When these two cell lines were studied in an in vitro system, elevated mRNA and protein levels of cell cycle regulators, p21(cip) and p27(kip) were detected in MCF-7 cells overexpressing PTPRG compared to cells transfected with vector alone. Similarly, overexpression of PTPRG also delayed the re-entry of breast cancer cells into the cell cycle after serum starvation, and reduced the phosphorylation levels ERK1/2 in MCF-7 cells. In addition, methylation assays in PTPRG promoter in breast cancer cell lines (including SK-Br-3) revealed an aberrant methylation pattern. When SK-Br-3 and MCF-7 cells were treated with deoxy-5-azacytidine (DAC) and trichostatin A (TSA), these compounds reactivated the expression of PTPRG, suggesting an epigenetic control on its expression. Conclusion: Our results indicated that PTPRG inhibited breast tumor formation in vivo; PTPRG may up-regulate p21(cip) and p27(kip) proteins through the ERK1/2 pathway. This study also showed methylation-mediated silencing of PTPRG in breast cancer cell lines. These data indicate that PTPRG exhibits the characteristics of a breast tumor suppressor.

Protein Tyrosine Phosphatase Μ (PTP Μ or PTPRM), a Negative Regulator of Proliferation and Invasion of Breast Cancer Cells, is Associated with Disease Prognosis.

Protein Tyrosine Phosphatase Kappa (PTPRK) is a Negative Regulator of Adhesion and Invasion of Breast Cancer Cells, and Associates with Poor Prognosis of Breast Cancer

Protein Tyrosine Phosphatase Receptor-Type Δ Acts As a Negative Regulator Suppressing Breast Cancer

Protein Tyrosine Phosphatase 1B Expression Contributes to the Development of Breast Cancer

Function and Regulatory Mechanisms of the Candidate Tumor Suppressor Receptor Protein Tyrosine Phosphatase Gamma (PTPRG) in Breast Cancer Cells.

Transmembrane Phosphatases and Cancer Development, the Role of Protein Tyrosine Phosphatase-Kappa (ptp) and Protein Tyrosine Phosphatase-Mu (ptp Mu)

Receptor-like Protein Tyrosine Phosphatase Κ Negatively Regulates the Apoptosis of Prostate Cancer Cells Via the JNK Pathway.

PTP1B Markedly Promotes Breast Cancer Progression and is Regulated by Mir-193A-3p

Expression and Tumor-Promoting Effect of Tyrosine Phosphatase Receptor Type N (PTPRN) in Human Glioma

High expression of PTPRM predicts poor prognosis and promotes tumor growth and lymph node metastasis in cervical cancer

Tyrosine Phosphatase PTPRO Deficiency in ERBB2-Positive Breast Cancer Contributes to Poor Prognosis and Lapatinib Resistance

Effect of PTPRB on Metastasis of Colorectal Carcinoma and Induction of Epithelial-Mesenchymal Transition.

Downregulation of PTPRT elevates the expression of survivin and promotes the proliferation, migration, and invasion of lung adenocarcinoma

Protein tyrosine phosphatase receptor U (PTPRU) is required for glioma growth and motility.

Protein tyrosine phosphatase 1B(PTP1B) promotes melanoma cells progression through Src activation

Protein Tyrosine Phosphatase Receptor Type O Expression in the Tumor Niche Correlates with Reduced Tumor Growth, Angiogenesis, Circulating Tumor Cells and Metastasis of Breast Cancer

Tumor-Derived Exosomal Protein Tyrosine Phosphatase Receptor Type O Polarizes Macrophage to Suppress Breast Tumor Cell Invasion and Migration

PTPRB promotes metastasis of colorectal carcinoma via inducing epithelial-mesenchymal transition

Knockdown of Protein Tyrosine Phosphatase Receptor U Inhibits Growth and Motility of Gastric Cancer Cells.

Protein Tyrosine Phosphatase Receptor S Acts as a Metastatic Suppressor in Malignant Peripheral Nerve Sheath Tumor via Profilin 1-Induced Epithelial-Mesenchymal Transition

PTPRO Represses ERBB2-driven Breast Oncogenesis by Dephosphorylation and Endosomal Internalization of ERBB2